BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15709184)

  • 1. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.
    Yu Z; Weinberger PM; Haffty BG; Sasaki C; Zerillo C; Joe J; Kowalski D; Dziura J; Camp RL; Rimm DL; Psyrri A
    Clin Cancer Res; 2005 Feb; 11(3):1160-6. PubMed ID: 15709184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
    Psyrri A; Yu Z; Weinberger PM; Sasaki C; Haffty B; Camp R; Rimm D; Burtness BA
    Clin Cancer Res; 2005 Aug; 11(16):5856-62. PubMed ID: 16115926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
    Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer.
    Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Sasaki C; Rimm DL; Psyrri A
    Clin Cancer Res; 2004 Sep; 10(17):5684-91. PubMed ID: 15355894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
    Lai JP; Tong CL; Hong C; Xiao JY; Tao ZD; Zhang Z; Tong WM; Betz CS
    Laryngoscope; 2002 Feb; 112(2):402-8. PubMed ID: 11889405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
    Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
    Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma.
    Morshed K; Skomra D; Korobowicz E; Szymański M; Polz-Dacewicz M; Gołabek W
    Acta Otolaryngol; 2007 Jul; 127(7):760-9. PubMed ID: 17573573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas.
    Tsuzuki H; Sunaga H; Ito T; Narita N; Sugimoto C; Fujieda S
    Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1071-8. PubMed ID: 16365220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
    Rodriguez-Pinilla M; Rodriguez-Peralto JL; Hitt R; Sanchez JJ; Ballestin C; Diez A; Sanchez-Verde L; Alameda F; Sanchez-Cespedes M
    Clin Cancer Res; 2004 Dec; 10(24):8486-92. PubMed ID: 15623629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma.
    Smith BD; Smith GL; Carter D; DiGiovanna MP; Kasowitz KM; Sasaki CT; Haffty BG
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):780-5. PubMed ID: 11448349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
    Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
    Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
    J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.
    Suwinski R; Jaworska M; Nikiel B; Grzegorz W; Bankowska-Wozniak M; Wojciech M; Krzysztof S; Dariusz L
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):438-46. PubMed ID: 19733016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
    Perisanidis C; Perisanidis B; Wrba F; Brandstetter A; El Gazzar S; Papadogeorgakis N; Seemann R; Ewers R; Kyzas PA; Filipits M
    J Oral Pathol Med; 2012 Jan; 41(1):40-6. PubMed ID: 21883486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
    Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
    Chang AR; Wu HG; Park CI; Jun YK; Kim CW
    Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
    Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
    Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.